Tai Chi Intervention for Balance Function in Older Adults: Predictive and Modifying Roles of Circadian Age
Effects of Tai Chi on Balance Function in Community-Dwelling Older Adults: A Randomized Controlled Trial Examining the Predictive and Modifying Roles of Circadian Age, With Multi-Omics and Brain Function Assessments
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
BACKGROUND AND RATIONALE Falls are a leading cause of injury and disability in older adults, and balance dysfunction is a key modifiable risk factor. Tai Chi, a traditional Chinese mind-body exercise, has been shown to improve balance, reduce fall risk, and benefit cognitive health in older populations. However, individual variability in response to Tai Chi remains poorly understood, and the biological mechanisms underlying its benefits are incompletely characterized.
Circadian rhythm disruption has emerged as a hallmark of biological aging. The investigators have developed and validated a circadian age (CircAge) assessment system based on the UK Biobank cohort (N>90,000), which independently predicts mortality risk. Whether individuals with accelerated circadian aging benefit more from Tai Chi intervention is unknown. This trial addresses this gap by integrating circadian age assessment with multi-modal outcome evaluations.
OBJECTIVES The primary objective is to evaluate the effect of a 12-week Tai Chi intervention on balance function in community-dwelling older adults. Secondary objectives are to assess effects on physical function, psychological health, cognitive function, and sleep quality. Exploratory objectives are to examine the predictive and modifying roles of baseline circadian age acceleration on intervention outcomes.
STUDY DESIGN This is a two-arm parallel, single-blind (assessor-blinded) randomized controlled trial. Ninety community-dwelling older adults are randomly allocated 1:1 to a Tai Chi group or a health education control group. Randomization is computer-generated using variable block sizes, stratified by sex and baseline Berg Balance Scale score (≤45 vs >45). Allocation concealment is maintained via sequentially numbered opaque sealed envelopes. Outcome assessors are blinded to group allocation. After the 12-week intervention, the control group is offered free Tai Chi classes to ensure ethical equipoise.
ASSESSMENT SCHEDULE Wrist-worn accelerometer (ActiGraph) recordings are collected at baseline over 7 consecutive days for circadian age computation. All baseline accelerometer recordings are completed prior to randomization. Full outcome assessments are conducted at baseline (week 0) and at the end of intervention (week 12). A streamlined midpoint assessment (week 6) includes only the Berg Balance Scale and Timed Up and Go test. Fasting blood samples for routine clinical chemistry are collected at week 0 and week 12.
STATISTICAL ANALYSIS A sample size of 90 (45 per group) provides >80% power to detect a standardized effect size of d=0.50 in Berg Balance Scale change at week 12, assuming α=0.05 (two-sided) and 20% attrition. The primary analysis follows the intention-to-treat principle using linear mixed-effects models adjusted for baseline score, age, sex, and circadian age acceleration, with class as a random effect for the Tai Chi group. Exploratory analyses include circadian age × group interaction terms.
LONG-TERM FOLLOW-UP After the 12-week intervention, participants are invited to enter a long-term health database with periodic follow-ups tracking balance function, fall events, and overall health status.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Zhide Liang, MS
- Numéro de téléphone: 0853-65597656
- E-mail: p2516238@mpu.edu.mo
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Aged 55 years or older
- Community-dwelling
- Able to walk independently (assistive devices such as canes are permitted)
- Berg Balance Scale (BBS) score ≤52 at screening
- Able to understand and follow verbal instructions
- Willing to wear a wrist accelerometer continuously for 7 days at baseline
- Willing to accept random group assignment
- Willing to undergo blood collection during the study
- Provides written informed consent
Exclusion Criteria:
- Regular Tai Chi or yoga practice (more than once per week) within the past 6 months
- Severe cognitive impairment (Montreal Cognitive Assessment [MoCA] score <20 at screening, or previously diagnosed dementia)
- Unstable cardiovascular disease (myocardial infarction, stroke, or hospitalization within the past 3 months)
- Severe musculoskeletal disease that limits exercise participation
- Neurological diseases affecting balance (e.g., Parkinson's disease, severe peripheral neuropathy)
- Currently participating in another exercise intervention study
- Planned surgery or extended absence during the study period
- Contraindications to functional near-infrared spectroscopy (fNIRS) examination (e.g., scalp injury, metallic implants in the head region)
- Severe psychiatric illness (e.g., schizophrenia, bipolar disorder)
- Considered unable to safely participate in moderate-intensity physical activity as judged by the study physician or attending healthcare provider
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Tai Chi Group
Participants in this group receive instruction in Yang-style 24-form Tai Chi from a nationally certified master coach.
Tai Chi classes are offered five days per week, and participants are required to attend at least three sessions per week.
Each session lasts 60 minutes, including warm-up, Tai Chi practice, cool-down, and Q&A.
The intervention duration is 12 weeks.
Class size is limited to 10-15 participants to ensure individualized guidance.
|
Yang-style 24-form Tai Chi taught by a nationally certified master coach.
Classes are offered five days per week, with participants required to attend at least three sessions per week, for a total of 12 weeks (target: ≥36 sessions).
Each 60-minute session includes a 10-minute warm-up, 35 minutes of Tai Chi practice, 10 minutes of cool-down (including standing meditation and breathing exercises), and 5 minutes for questions and home practice reminders.
Class size is limited to 10-15 participants.
|
|
Comparateur actif: Health Education Control Group
Participants in this group attend health education seminars led by professional medical and health management staff.
Seminar topics include nutrition, chronic disease management, fall prevention, and safe medication use.
The intervention duration is 12 weeks.
After the intervention ends, this group is offered free Tai Chi classes to ensure ethical equipoise.
|
Structured health education program delivered by professional medical and health management staff.
Seminars cover topics including nutrition and dietary guidance, chronic disease management (hypertension, diabetes), fall prevention strategies, safe medication use, and general health literacy for older adults.
The intervention runs for 12 weeks.
Participants receive the same health screening, evaluation, and feedback benefits as the Tai Chi group.
Free Tai Chi classes are offered to this group after the intervention period ends.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Berg Balance Scale (BBS) Score
Délai: Change from baseline to end of intervention, up to 12 weeks
|
The Berg Balance Scale (BBS) is a 14-item performance-based measure of static and dynamic balance.
Each item is scored 0-4 based on the participant's ability to perform tasks such as sitting to standing, transfers, standing unsupported with eyes closed, turning, and single-leg stance.
Total scores range from 0 to 56, with higher scores indicating better balance function.
Lower scores are associated with increased fall risk.
|
Change from baseline to end of intervention, up to 12 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in Single-Leg Eye-Closed Standing Time
Délai: Change from baseline to end of intervention, up to 12 weeks
|
Static balance is assessed by measuring the time (in seconds) participants can maintain single-leg standing with eyes closed.
Both legs are tested.
Longer times indicate better static balance and proprioception.
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Vertical Jump Height
Délai: Change from baseline to end of intervention, up to 12 weeks
|
Vertical jump test measures lower-extremity power and neuromuscular function.
Participants perform three consecutive jumps, and the maximum jump height (in centimeters) is recorded.
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Reaction Time
Délai: Change from baseline to end of intervention, up to 12 weeks
|
Reaction time test measures central nervous system processing speed using a portable reaction time device.
Faster reaction times are associated with lower fall risk and better cognitive processing.
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Activities-Specific Balance Confidence (ABC) Scale
Délai: Change from baseline to end of intervention, up to 12 weeks
|
The ABC Scale is a 16-item self-report measure of balance confidence during specific activities (e.g., walking, reaching, climbing stairs).
Each item is rated 0-100%, with higher scores indicating greater balance confidence.
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Geriatric Depression Scale (GDS-15) Score
Délai: Change from baseline to end of intervention, up to 12 weeks
|
The 15-item Geriatric Depression Scale (GDS-15) screens for depressive symptoms in older adults.
Total scores range from 0 to 15, with scores ≥5 suggesting depression.
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Generalized Anxiety Disorder Scale (GAD-7) Score
Délai: Change from baseline to end of intervention, up to 12 weeks
|
The 7-item Generalized Anxiety Disorder Scale (GAD-7) measures anxiety severity.
Total scores range from 0 to 21, with scores ≥10 indicating moderate-to-severe anxiety.
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Pittsburgh Sleep Quality Index (PSQI) Score
Délai: Change from baseline to end of intervention, up to 12 weeks
|
The Pittsburgh Sleep Quality Index (PSQI) is a 19-item self-report questionnaire assessing sleep quality over the past month.
Total scores range from 0 to 21, with scores >5 indicating poor sleep quality.
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Timed Up and Go (TUG) Test
Délai: Change from baseline to end of intervention, up to 12 weeks
|
Functional mobility and dynamic balance test.
Participants stand from an armed chair, walk 3 meters, turn, walk back, and sit down.
Time to complete the task is recorded in seconds.
Longer times indicate poorer mobility and higher fall risk.
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Grip Strength
Délai: Change from baseline to end of intervention, up to 12 weeks
|
Maximum grip strength measured using a handheld dynamometer, in kilograms. Three trials per hand; maximum value recorded. Higher values indicate greater muscle strength. Time Frame: Change from baseline to 12 weeks |
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Balance Performance Measured by InBody Balance Trainer
Délai: Change from baseline to end of intervention, up to 12 weeks
|
Static balance assessed via center-of-pressure trajectory recorded by the InBody Balance Trainer during quiet standing, reported in millimeters.
Shorter path length indicates better postural control.
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Change in Shape Trail Test (STT) Part A and Part B Completion Time
Délai: Change from baseline to end of intervention, up to 12 weeks
|
The Shape Trail Test (STT) is a culturally adapted variant of the Trail Making Test developed for Chinese populations, avoiding reliance on the Latin alphabet.
In Part A, participants connect numbered circles in sequence; in Part B, they alternate between circles and squares while ignoring the numbers.
Completion time for each part is recorded in seconds, with longer times indicating poorer processing speed and executive function.
STT-A and STT-B completion times are reported separately.
|
Change from baseline to end of intervention, up to 12 weeks
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Changes in Blood Metabolomic and Proteomic Profiles
Délai: Change from baseline to end of intervention, up to 12 weeks
|
Targeted and untargeted metabolomics analysis of serum and plasma samples; proteomics analysis (Olink/SomaScan platform) including inflammatory markers (IL-6, TNF-α, hs-CRP), aging-related proteins (GDF-15), and neurotrophic factors (BDNF).
|
Change from baseline to end of intervention, up to 12 weeks
|
|
Baseline Circadian Age Acceleration (AgeAccel_z)
Délai: Baseline
|
Circadian age acceleration is derived from 7-day wrist-worn accelerometer (ActiGraph) data processed using the GGIR R package.
AgeAccel_z is the standardized residual of circadian age regressed on chronological age, reported in standard deviation units (z-score).
Positive values indicate accelerated circadian aging relative to chronological age.
|
Baseline
|
|
Changes in Serum Metabolomic Profiles
Délai: Change from baseline to 12 weeks
|
Targeted and untargeted metabolomics analysis of serum samples.
Differential metabolites between groups are identified using fold change (|FC|>1.2) and false discovery rate (FDR<0.1).
Results are reported as the number of significantly altered metabolites and enriched metabolic pathways.
|
Change from baseline to 12 weeks
|
|
Changes in Serum Proteomic Profiles
Délai: Change from baseline to 12 weeks
|
Proteomic analysis using Olink or SomaScan platform measuring inflammation-related proteins (IL-6, TNF-α, hs-CRP, IL-1β), aging-related proteins (GDF-15, IGFBP-3), and neurotrophic factors (BDNF, NGF).
Differential proteins between groups are identified using fold change (|FC|>1.5)
and false discovery rate (FDR<0.1).
Results are reported as the number of significantly altered proteins.
|
Change from baseline to 12 weeks
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Directeur d'études: Baichao Xu, PhD, Hainan Medical College
- Directeur d'études: Ziheng Ning, PhD, Macao Polytechnic University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- HainanMC-TaiChi-2026-001
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .